Hubei Biocause Heilen Pharmaceutical Co., Ltd. (301211.SZ) SHZ
9.80
-0.18(-1.80%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
9.80
-0.18(-1.80%)
Currency In CNY
Sector
Basic Materials
Industry
Chemicals
Employees
1012
First IPO Date
December 22, 2021
| Name | Title | Pay | Year Born |
| Ting Hao Yi | Financial Director | 0 | 1973 |
| Weihua Zhu | Deputy General Manager | 0 | 1967 |
| Kuili Zhang | Deputy General Manager | 0 | 1976 |
| Qianqian Guan | Deputy General Manager | 0 | 1983 |
| Chun Hua Quan | Accounting Supervisor | 0 | N/A |
| Qun Liang | General Manager | 0 | 1971 |
| Chunli Yang | Executive Vice President & Director | 0 | 1970 |
| Jian Gao | Board Secretary | 0 | 1977 |
| Zhenghua Huang | Deputy General Manager | 0 | 1972 |
Hubei Biocause Heilen Pharmaceutical Co., Ltd. engages in the pharmaceutical, chemical, and new energy fuel businesses in China. It provides APIs and intermediates, and formulations; and dimethyl ether gas and chloropropionyl chloride chemical products. The company is based in Jingmen, China.